Welcome to Medications.com

Cephalon Posts Q4 Profit On Lower Expenses; Guides Q1, Reiterates ... - RTT News

Sales of cancer pain drug Actiq dropped 50% to $54.3 million due to generic competition. Pain drug Fentora sold 16% more at $33.9 million. ...

Posted: Tue Feb 12 18:19:10 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea